Pharma News | GDS Publishing

Home
/
Latest News

The Magazine

Current Issue

How the health reform is looking out for the industry in the long-term.

- Issue 19
  Jun 2010
- Issue 18
  Feb 2010
- Issue 17
  Sep 2009
- Issue 16
  Jun 2009
- Issue 15
  Feb 2009
- Issue 14
  Oct 2008
- Issue 13
  Jul 2008
- Issue 12
  Mar 2008
- Issue 11
  Dec 2007
- Issue 10
  Oct 2007
- Issue 9
  Jul 2007
- Issue 8
  Apr 2007
- Issue 7
  Jan 2007
- Issue 6
  Dec 2006
- Issue 5
  Oct 2006
- Issue 4
  Mar 2006
- Issue 3
  Mar 2006
- Issue 2
  Mar 2006
- Issue 1
  Mar 2006

Blog

Spencer Green
Chairman, GDS International

Latest News

Top 10 Pharma Layoffs of 2010

After cutting out 7000 employees last year, BMS only just made this year’s cut with its September...

read more
Comments

CureFAKtor Pharmaceuticals Receives Orphan Drug Designation

CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the...

read more
Comments

Pharma to See Big Growth in East in 2011

According to investment international, 2011 will be a successful year for the pharmaceutical...

read more
Comments

Neovacs: Crohn's Disease Immunotherapy Trial Success

Neovacs, a biotechnology company focused on active immunotherapy for autoimmune and inflammatory...

read more
Comments

Aspirin Reduces Cancer Risk by 21%

British researchers revealed in an article published in The Lancet that a daily dose in the range...

read more
Comments

Ian Read to Replace Jeffrey Kindler as Pfizer CEO

Pfizer, the world's largest pharmaceutical company has announced that CEO Jeffrey Kindler has...

read more
Comments

Survey: FDA and Industry Relationship Complicated

PricewaterhouseCoopers (PwC) most recent survey ‘Improving America’s Health V- A survey of the...

read more
Comments

Johnson & Johnson Recalls Benadryl Allergy Tablets

Johnson & Johnson has recalled four million packages of Children's Benadryl allergy tablets and...

read more
Comments

Resverlogix Announces Top ASSERT Results

Resverlogix Corp. (Resverlogix) (TSX:RVX) announces its top line results of the ASSERT Phase 2...

read more
Comments

Warfarin Shown to be Less Effective Than Xarelto in Study

Johnson & Johnson’s Warfarin, the gold standard anti-clotting drug has been shown to be less...

read more
Comments

Next Generation Healthcare Summit

Next Generation Healthcare Summit
25th - 27th October 2010

As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.

Summit Highlights

Source: www.ngpharma.com
© 2013 GDS Publishing Ltd. All rights reserved.